Deciphering a novel interplay between RNA and chromatin
Lead Research Organisation:
Queen Mary University of London
Department Name: Barts Cancer Institute
Abstract
Each cell in our body contains the same genetic information, yet this information is decoded in vastly different manners, allowing different cells to acquire distinct roles, which are together needed for the proper functioning of our tissues and organs. The genetic information is stored in DNA molecules, which reside in a part of the cell called the nucleus. In the nucleus, DNA is wrapped around a group of specialised proteins called histones, forming a DNA-protein structure known as chromatin. This protects the DNA from damage, and regulates access to the genetic information, which is crucial for determining which genes can be decoded at any given time. The packaging of chromatin therefore needs to be accurately controlled at all times, but it is not fully clear exactly his this is achieved in our cells.
Our preliminary results have revealed that an important chromatin protein named histone H1 can also bind to RNA molecules. RNA molecules are intermediate molecules which mediate the decoding of genetic information from DNA, but recent findings suggest they can also control chromatin. Our aim now is to understand how histone H1 binds to RNA, and how this binding affects the decoding of genetic information and the structure of chromatin. To do this, we will use a variety of cutting-edge approaches to investigate how histone H1 interaction with RNA is regulated in cells. We will then reveal the impact of histone H1 binding to RNA on the decoding of genetic information. Finally, we will assess how changes in histone H1 function can control different cell behaviours such as cell-division. Addressing these fundamental questions will greatly advance our understanding of chromatin biology and its regulation, opening up new opportunities for modulating chromatin function in biotechnology (e.g. cell reprogramming) and medicine (new therapeutic targets).
Our preliminary results have revealed that an important chromatin protein named histone H1 can also bind to RNA molecules. RNA molecules are intermediate molecules which mediate the decoding of genetic information from DNA, but recent findings suggest they can also control chromatin. Our aim now is to understand how histone H1 binds to RNA, and how this binding affects the decoding of genetic information and the structure of chromatin. To do this, we will use a variety of cutting-edge approaches to investigate how histone H1 interaction with RNA is regulated in cells. We will then reveal the impact of histone H1 binding to RNA on the decoding of genetic information. Finally, we will assess how changes in histone H1 function can control different cell behaviours such as cell-division. Addressing these fundamental questions will greatly advance our understanding of chromatin biology and its regulation, opening up new opportunities for modulating chromatin function in biotechnology (e.g. cell reprogramming) and medicine (new therapeutic targets).
Technical Summary
It is well-known that many signalling pathways control gene expression through modulating chromatin. However, the molecular mechanisms that regulate different aspects of chromatin structure and function in response to distinct signalling inputs are poorly characterised. A key group of chromatin regulators are the linker histone (H1) family of proteins, which promote chromatin condensation by interacting with the linker DNA regions that connect nucleosomes. Histone H1 binding to linker DNA leads to direct compaction of chromatin, as well as indirectly promoting heterochromatin formation by impairing the access of chromatin modulators to nucleosomes. Previous studies have revealed a pivotal role for histone H1 in controlling diverse aspects of cell behaviour, from regulation of gene expression to DNA replication and mitosis. However, the mechanisms that modulate histone H1 activity in response to distinct signalling inputs have remained largely unknown. Exciting preliminary results from our laboratory have revealed that upon activation of RAS-MAPK signalling, a pivotal signal transduction pathway that controls key cellular decisions such as cell-proliferation and differentiation, histone H1 directly binds to RNA. Using a state-of-art multi-disciplinary approach, we now aim to characterise this novel function of histone H1 in detail, defining the molecular mechanisms that control the RNA-binding activity of H1, the identity and regulation of its target RNAs, as well as the functional consequence of this association on chromatin biology, transcriptional and post-transcriptional regulation of gene expression, and cell-cycle progression.
Publications
Dodel M
(2024)
TREX reveals proteins that bind to specific RNA regions in living cells.
in Nature methods
Related Projects
| Project Reference | Relationship | Related To | Start | End | Award Value |
|---|---|---|---|---|---|
| BB/X007820/1 | 23/04/2023 | 29/08/2024 | £634,167 | ||
| BB/X007820/2 | Transfer | BB/X007820/1 | 30/08/2024 | 22/10/2026 | £387,125 |
| Description | One of the key aims of the award to identify RNA interactors of Histone H1 has been achieved, thanks to a largescale iCLIP analysis of H1. This has revealed key insights into the novel RNA binding function of H1, which was one of the main aims of this grant. |
| Exploitation Route | We will release the largescale H1 iCLIP datasets as a database along with the primary publication reporting the findings. These can be mined by any other researcher for their use. |
| Sectors | Healthcare Pharmaceuticals and Medical Biotechnology |
| Description | Understanding and exploiting ribosome biogenesis dysregulation in cancer |
| Amount | £1,428,946 (GBP) |
| Funding ID | DRCPFA-Nov24/100005 |
| Organisation | University of Oxford |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 03/2025 |
| End | 02/2031 |
| Title | Targeted RNAse-H mediated Extraction of X-linked RBPs (TREX) |
| Description | Different regions of RNA molecules often engage in specific interactions with distinct RNA-binding proteins (RBPs), giving rise to diverse modalities of RNA regulation and function. However, no methods existed for unbiased identification of RBPs that interact with specific RNA regions in living cells and under endogenous settings. To address this critical unmet need in the RNA biology field, we developed TREX (targeted RNase H-mediated extraction of crosslinked RBPs)-a highly sensitive approach for identifying proteins that directly bind to specific RNA regions in living cells. With its applicability to different cell types and RNA molecules of interests, TREX is a groundbreaking RNA-centric tool for unbiased positional mapping of endogenous RNA-protein interactions in living cells. |
| Type Of Material | Technology assay or reagent |
| Year Produced | 2024 |
| Provided To Others? | Yes |
| Impact | TREX has been a ground-breaking method for studying region-specific RNA-protein interactions. Its publication in Nature Method has been followed by an enthusiastic reception from the field, with many labs adapting the technology for their specific needs. |
| URL | https://www.nature.com/articles/s41592-024-02181-1 |
| Description | Collaboration with Dr Paola Scaffidi on characterizing H1 binding to RNA |
| Organisation | European Institute of Oncology (IEO) |
| Country | Italy |
| Sector | Academic/University |
| PI Contribution | My teams have recently discovered a novel link between Histone H1 and RNA. In this collaboration, we have come together with Dr Scaffidi to analyse H1 regulation by RNA in greater detail. Specifically, my team will characterise the RNA-protein interactions involved using various RNA and proteomics based methods we have developed in my lab, as well as the cellular consequences of H1 binding to RNA. |
| Collaborator Contribution | Dr Scaffidi in return will help with characterisation of the impact of H1 RNA binding on chromatin, an area in which her team is internationally renowned for. Specifically, Dr Scaffidi's team will help us carry out detailed genome-wide analysis of H1 binding patterns to chromatin upon regulated RNA binding, using various state-of-art methodologies such as ATAC-seq, FAIRE-seq, and ChIP-seq. |
| Impact | No outputs yet. This collaboration is multi-disciplinary, with expertise of my team focused on RNA and protein biology, while Dr Scaffidi's expertise cover the chromatin and DNA site. |
| Start Year | 2023 |
| Description | Collaboration with Prof. Jernej Ule |
| Organisation | Francis Crick Institute |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | A Bi-lateral collaboration has been formed with Professor Jernej Ule at the Crick Institute. This was suggested by one of the reviewers of my grant application, as professor Ule is a leading expert in study of RNA-Protein interactions. We have been performing proteomics runs and data analysis for professor Ule's group in return. |
| Collaborator Contribution | In return, professor Ule's lab has been heavily assisting us with the design and optimisation of our ICLIP experiments, as well as cross-linking and fractionation RNA-sequencing analyses. They have also been carrying out our next-generation sequencing runs at the Crick. The crosslinking and fractionation RNA-sequencing analyses directly led to an MRC project grant (The role of RNA localisation in cancer progression), providing the bulk of preliminary data for this application. |
| Impact | 1 - Comprehensive proteomics analysis of subcellular compartments in cells lacking HuR and Staufen (Prof. Ule's project). 2- Optimisation of cross-linking procedure for assessment of subcellular RNA bound by RBPs (our project - ongoing with project further supported by an MRC project grant awarded in 2020). 3- comprehensive RNA-seq analysis of subcellularly localised RBP-bound RNAs by UV cross-linking and RNA-sequencing (our project - ongoing). 4- iCLIP analysis of LARP6 as part of our project, which led to a joint publication in Developmental Cell (doi: 10.1016/j.devcel.2020.10.006). 5- iCLIP analysis of Nucleolin as part of our project, which led to a joint preprint (doi: https://doi.org/10.1101/2021), currently accepted in EMBO Journal. 6- iCLIP analysis of Histone H1 as part of our project (ONGOING). |
| Start Year | 2017 |
| Title | TREX: A method for region-specific mapping of proteins that bind to specific RNA regions in living cells. |
| Description | Different regions of RNA molecules often engage in specific interactions with distinct RNA-binding proteins (RBPs), giving rise to diverse modalities of RNA regulation and function. However, no methods existed for unbiased identification of RBPs that interact with specific RNA regions in living cells and under endogenous settings. To address this critical unmet need in the RNA biology field, we developed TREX (targeted RNase H-mediated extraction of crosslinked RBPs)-a highly sensitive approach for identifying proteins that directly bind to specific RNA regions in living cells. With its applicability to different cell types and RNA molecules of interests, TREX is a groundbreaking RNA-centric tool for unbiased positional mapping of endogenous RNA-protein interactions in living cells. |
| IP Reference | 2302947.3 |
| Protection | Patent / Patent application |
| Year Protection Granted | 2023 |
| Licensed | No |
| Impact | Licencing negotiations are in progress. |
